Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target Raised to $55.00 at Robert W. Baird

Mirum Pharmaceuticals (NASDAQ:MIRM – Get Free Report) had its price target upped by analysts at Robert W. Baird from $50.00 to $55.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Robert W. Baird’s target price points to a potential upside of […]

Mar 1, 2025 - 09:45

Mirum Pharmaceuticals (NASDAQ:MIRM – Get Free Report) had its price target upped by analysts at Robert W. Baird from $50.00 to $55.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Robert W. Baird’s target price points to a potential upside of […]